Urologix, Inc. (ULGX)
Minneapolis, MN, US
Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the United States. The company's innovative solutions target the treatment of obstructions and related symptoms caused by benign prostatic hyperplasia (BPH). Among its key offerings is Cooled ThermoTherapy, a system that precisely applies microwave energy while simultaneously employing a cooling mechanism to safeguard healthy tissues and improve patient comfort. Urologix also provides the Prostiva RF Therapy System, which directs radio frequency energy into the prostate gland. This process works to eliminate problematic prostatic tissue, consequently easing urethral constriction and alleviating BPH-related discomfort. Urologix, Inc. caters to both healthcare professionals and patients.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -50.00% | +0.00% | +0.00% | +0.00% | +0.00% | -98.80% | -95.71% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%-14.2% Q1'15: -16.7% (vs Q1'14)
-
EPS growth Medical - Devices: +28.5%-71.4% Q1'15: +79.5% (vs Q1'14)
-
FCF margin FCF growth · Medical - Devices: +30.9%-41.5% Q1'15: -1.5% (vs Q1'14)
-
EBIT margin Medical - Devices: +6.2%-48.7% Q1'15: -5.5% (vs Q1'14)
-
ROIC Medical - Devices: +3.3%— Q1'15: +19.0% (vs Q1'14)
-
Share dilution Medical - Devices: 0.0%+2.5% Q1'15: +2.4% (vs Q1'14)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.84× Q1'15: -31.74× (vs Q1'14)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 41-1501962 | 5.73M | 28.60% | 4.48M | — | 5.73M | — | IA | State of Minnesota | 2012-07-12 | ↗ |
| 2 | PATRICOF & CO. VENTURES, INC. / 13-2647531 | 909.1K | 9.90% | 32.7K | 876.4K | 32.7K | 876.4K | CO | NEW YORK | 1997-02-05 | ↗ |
| 3 | Wells Fargo & Company | 719.8K | 5.20% | 589.2K | — | 709.4K | 9.9K | HC | Delaware | 2002-02-12 | ↗ |
| 4 | (. | 605.3K | 4.19% | 598.1K | — | 605.3K | — | IA | Delaware Limited Partnership | 2009-02-09 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-11-20 | EMERY SIDNEY W JR | Director | S-Sale | D | Common Stock | 10,000 | 0.09 | 854.00 | 164,031 | — | ↗ |
| 2014-11-19 | EMERY SIDNEY W JR | Director | S-Sale | D | Common Stock | 10,000 | 0.09 | 854.00 | 174,031 | — | ↗ |
| 2014-11-06 | EMERY SIDNEY W JR | Director | A-Award | A | Common Stock | 45,455 | 0.00 | — | 184,031 | — | ↗ |
| 2013-11-07 | EMERY SIDNEY W JR | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 138,576 | — | ↗ |
| 2012-11-16 | EMERY SIDNEY W JR | Director | A-Award | A | Common Stock | 26,516 | 0.00 | — | 88,576 | — | ↗ |
| 2012-06-29 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 20,000 | 0.75 | 15.0K | 62,060 | — | ↗ |
| 2011-12-06 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 5,000 | 1.02 | 5.1K | 20,000 | — | ↗ |
| 2011-12-02 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 100 | 1.00 | 100.00 | 15,000 | — | ↗ |
| 2011-12-01 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 10,000 | 1.02 | 10.2K | 10,000 | — | ↗ |
| 2011-11-08 | EMERY SIDNEY W JR | Director | A-Award | A | Common Stock | 18,042 | 0.00 | — | 42,060 | — | ↗ |
| 2010-11-09 | EMERY SIDNEY W JR | Director | A-Award | A | Common Stock | 15,244 | 0.00 | — | 24,018 | — | ↗ |
| 2009-11-17 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 5,000 | 1.00 | 5.0K | 10,000 | — | ↗ |
| 2009-11-16 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 5,000 | 0.95 | 4.8K | 59,154 | — | ↗ |
| 2009-11-10 | MOORE WILLIAM M | Director | A-Award | A | Common Stock | 8,774 | 0.00 | — | 54,154 | — | ↗ |
| 2009-11-10 | Jackson Guy C. | Director | A-Award | A | Common Stock | 8,774 | 0.00 | — | 16,774 | — | ↗ |
| 2009-11-10 | EMERY SIDNEY W JR | Director | A-Award | A | Common Stock | 8,774 | 0.00 | — | 8,774 | — | ↗ |
| 2009-05-12 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 1,500 | 0.85 | 1.3K | 45,380 | — | ↗ |
| 2009-05-04 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 100 | 0.85 | 85.00 | 43,880 | — | ↗ |
| 2009-05-01 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 200 | 0.82 | 164.00 | 43,217 | — | ↗ |
| 2009-04-30 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 1,500 | 0.85 | 1.3K | 42,280 | — | ↗ |
| 2008-11-11 | STARKS DANIEL J | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 0.79 | 7.9K | 10,000 | — | ↗ |
| 2008-11-11 | MOORE WILLIAM M | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 0.79 | 7.9K | 10,000 | — | ↗ |
| 2008-11-11 | Jackson Guy C. | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 0.79 | 7.9K | 10,000 | — | ↗ |
| 2008-11-11 | EMERY SIDNEY W JR | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 0.79 | 7.9K | 10,000 | — | ↗ |
| 2008-05-23 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 10,000 | 1.18 | 11.8K | 51,247 | — | ↗ |
| 2008-05-21 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 500 | 1.11 | 555.00 | 40,780 | — | ↗ |
| 2008-05-14 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 480 | 0.98 | 470.40 | 40,280 | — | ↗ |
| 2008-05-13 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 1,000 | 0.95 | 950.00 | 35,800 | — | ↗ |
| 2008-05-12 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 1,000 | 0.93 | 930.00 | 33,800 | — | ↗ |
| 2008-05-09 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 800 | 0.93 | 744.00 | 32,800 | — | ↗ |
| 2008-05-08 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 1,000 | 0.91 | 910.00 | 27,000 | — | ↗ |
| 2008-05-07 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 1,000 | 0.93 | 930.00 | 26,000 | — | ↗ |
| 2008-03-07 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 2,000 | 0.98 | 2.0K | 25,000 | — | ↗ |
| 2008-03-05 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 2,000 | 0.95 | 1.9K | 18,000 | — | ↗ |
| 2008-03-04 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 2,000 | 1.04 | 2.1K | 16,000 | — | ↗ |
| 2008-03-03 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 3,000 | 1.08 | 3.2K | 9,000 | — | ↗ |
| 2008-02-29 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 2,000 | 1.05 | 2.1K | 2,000 | — | ↗ |
| 2008-02-28 | MOORE WILLIAM M | Director | P-Purchase | A | Common Stock | 2,000 | 1.04 | 2.1K | 4,000 | — | ↗ |
| 2008-02-25 | MOORE WILLIAM M | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.78 | 7.8K | 10,000 | — | ↗ |
| 2007-11-06 | STARKS DANIEL J | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 1.66 | 16.6K | 10,000 | — | ↗ |
| 2007-11-06 | JACKSON GUY C | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 1.66 | 16.6K | 10,000 | — | ↗ |
| 2007-11-06 | EMERY SIDNEY W JR | Director | A-Award | A | Stock Option (Right-to-Buy) | 10,000 | 1.66 | 16.6K | 10,000 | — | ↗ |
| 2006-11-14 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 2,000 | 2.40 | 4.8K | 25,247 | — | ↗ |
| 2006-11-07 | STARKS DANIEL J | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.49 | 24.9K | 10,000 | — | ↗ |
| 2006-11-07 | JACKSON GUY C | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.49 | 24.9K | 10,000 | — | ↗ |
| 2006-11-07 | EMERY SIDNEY W JR | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.49 | 24.9K | 10,000 | — | ↗ |
| 2006-10-31 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 3,011 | 2.45 | 7.4K | 23,247 | — | ↗ |
| 2006-08-22 | STARKS DANIEL J | Director | P-Purchase | A | Common Stock | 2,346 | 2.92 | 6.9K | 30,000 | — | ↗ |
| 2006-08-21 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 6,000 | 2.85 | 17.1K | 18,236 | — | ↗ |
| 2006-06-06 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 2,000 | 3.42 | 6.8K | 12,236 | — | ↗ |
| 2006-05-17 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 936 | 3.26 | 3.1K | 10,236 | — | ↗ |
| 2006-05-03 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 3,000 | 3.40 | 10.2K | 9,300 | — | ↗ |
| 2006-02-01 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 5,500 | 3.70 | 20.4K | 6,300 | — | ↗ |
| 2005-11-25 | EMERY SIDNEY W JR | Director | P-Purchase | A | Common Stock | 500 | 4.30 | 2.2K | 800 | — | ↗ |
| 2005-11-08 | STARKS DANIEL J | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 4.04 | 40.4K | 10,000 | — | ↗ |
| 2005-11-08 | JACKSON GUY C | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 4.04 | 40.4K | 10,000 | — | ↗ |
| 2005-11-08 | GRIFFIN BOBBY IVAN | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 4.04 | 40.4K | 10,000 | — | ↗ |
| 2005-11-08 | EMERY SIDNEY W JR | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 4.04 | 40.4K | 10,000 | — | ↗ |
| 2005-11-03 | JACKSON GUY C | Director | P-Purchase | A | Common Stock | 5,000 | 3.95 | 19.8K | 5,000 | — | ↗ |
| 2005-10-03 | EMERY SIDNEY W JR | Director | — | D | Common Stock | 0 | 0.00 | — | 300 | — | ↗ |
| 2005-07-15 | MONTECALVO DAVID A | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 5.47 | 136.8K | 25,000 | — | ↗ |
| 2004-11-19 | JACKSON GUY C | Director | P-Purchase | A | Common Stock | 900 | 6.40 | 5.8K | 3,000 | — | ↗ |
| 2004-11-09 | STARKS DANIEL J | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 6.89 | 68.9K | 10,000 | — | ↗ |
| 2004-11-09 | JACKSON GUY C | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 6.89 | 68.9K | 10,000 | — | ↗ |
| 2004-11-09 | GRIFFIN BOBBY IVAN | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 6.89 | 68.9K | 10,000 | — | ↗ |
| 2004-11-09 | FOOTE SUSAN BARTLETT | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 6.89 | 68.9K | 10,000 | — | ↗ |
| 2004-07-19 | MONTECALVO DAVID A | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 12.23 | 305.8K | 25,000 | — | ↗ |
| 2003-12-15 | JACKSON GUY C | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 6.40 | 64.0K | 10,000 | — | ↗ |
| 2003-11-11 | STARKS DANIEL J | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 5.25 | 52.5K | 10,000 | — | ↗ |
| 2003-11-11 | GRIFFIN BOBBY IVAN | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 5.25 | 52.5K | 10,000 | — | ↗ |
| 2003-11-11 | FOOTE SUSAN BARTLETT | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 5.25 | 52.5K | 10,000 | — | ↗ |
| 2003-07-21 | MONTECALVO DAVID A | Officer | A-Award | A | Option (right to buy) | 22,500 | 3.35 | 75.4K | 22,500 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2014 | Lisa A. Ackermann Executive Vice President, Sales and Marketing | 210.0K | — | 4.2K | — | 20.0K | 7.8K | 242.0K | 1.72% | ↗ |
| 2 | 2014 | Gregory J. Fluet Chief Executive Officer | 200.0K | — | 6.2K | — | 25.0K | — | 231.2K | 2.70% | ↗ |
| 3 | 2014 | Brian J. Smrdel Chief Financial Officer | 135.0K | — | — | — | — | — | 135.0K | 0.00% | ↗ |
| 4 | 2013 | Lisa A. Ackermann Executive Vice President, Sales and Marketing | 210.0K | — | — | 10.3K | 20.0K | 55.8K | 296.1K | 3.46% | ↗ |
| 5 | 2013 | Gregory J. Fluet Chief Executive Officer | 200.0K | — | 15.0K | 12.3K | — | — | 227.3K | 12.01% | ↗ |
| 6 | 2013 | Stryker Warren Former Chief Executive Officer | 204.0K | — | — | — | — | 1.3K | 205.3K | 0.00% | ↗ |
| 7 | 2013 | Brian J. Smrdel Chief Financial Officer | 135.0K | — | — | 10.1K | — | — | 145.1K | 6.98% | ↗ |
| 8 | 2012 | Stryker Warren Former Chief Executive Officer | 272.0K | — | — | — | — | — | 272.0K | 0.00% | ↗ |
| 9 | 2012 | Stryker Warren Chief Executive Officer | 272.0K | — | — | — | — | — | 272.0K | 0.00% | ↗ |
| 10 | 2012 | Gregory J. Fluet Executive Vice President and Chief Operating Officer | 200.0K | — | — | 23.0K | 22.2K | — | 245.2K | 9.38% | ↗ |
| 11 | 2012 | Gregory J. Fluet Chief Executive Officer | 200.0K | — | — | 23.0K | 22.2K | — | 245.2K | 9.38% | ↗ |
| 12 | 2012 | Lisa A. Ackermann Executive Vice President, Sales and Marketing | 210.0K | — | — | — | 16.0K | 7.8K | 233.8K | 0.00% | ↗ |
| 13 | 2012 | Brian J. Smrdel Chief Financial Officer | 135.0K | — | — | 9.2K | 10.9K | — | 155.1K | 5.93% | ↗ |
| 14 | 2012 | Ralph P. Cardinal Vice President, Research and Development | 118.0K | — | — | — | — | — | 118.0K | 0.00% | ↗ |
| 15 | 2011 | Stryker Warren Chief Executive Officer | 272.0K | — | — | 31.9K | — | — | 303.9K | 10.48% | ↗ |
| 16 | 2011 | Gregory J. Fluet Executive Vice President and Chief Operating Officer | 155.0K | — | — | 27.0K | 4.7K | — | 186.7K | 14.44% | ↗ |
| 17 | 2011 | Ralph P. Cardinal Vice President Research and Development | 180.0K | — | — | — | 5.4K | — | 185.4K | 0.00% | ↗ |
| 18 | 2011 | Ralph P. Cardinal Vice President, Research and Development | 180.0K | — | — | — | 5.4K | — | 185.4K | 0.00% | ↗ |
| 19 | 2011 | Brian J. Smrdel Chief Financial Officer | 135.0K | — | — | — | 4.1K | — | 139.1K | 0.00% | ↗ |
| 20 | 2011 | Lisa A. Ackermann Executive Vice President, Sales and Marketing | — | — | — | 53.0K | — | — | 53.0K | 100.00% | ↗ |
| 21 | 2010 | Stryker Warren Chief Executive Officer | 272.0K | — | — | 67.0K | — | — | 339.0K | 19.76% | ↗ |
| 22 | 2010 | Gregory J. Fluet Executive Vice President, Chief Operating Officer | 150.0K | — | — | 33.5K | 42.8K | — | 226.3K | 14.81% | ↗ |
| 23 | 2010 | Gregory J. Fluet Executive Vice President and Chief Operating Officer | 150.0K | — | — | 33.5K | 42.8K | — | 226.3K | 14.81% | ↗ |
| 24 | 2010 | Rebecca J. Weber Controller and Dir. of Finance | 106.6K | — | — | 10.1K | 26.6K | — | 143.2K | 7.02% | ↗ |
| 25 | 2010 | Brian J. Smrdel Chief Financial Officer | 15.6K | — | — | 48.8K | — | — | 64.3K | 75.78% | ↗ |
| 26 | 2010 | Ralph P. Cardinal Vice President Research and Development | 11.1K | — | — | 45.0K | — | — | 56.1K | 80.25% | ↗ |
| 27 | 2009 | Stryker Warren Chief Executive Officer | 298.9K | — | — | — | — | 2.0K | 300.9K | 0.00% | ↗ |
| 28 | 2009 | Gregory J. Fluet Executive Vice President, Chief Operating Officer | 147.1K | — | — | 53.3K | 27.0K | 7.5K | 234.9K | 22.67% | ↗ |
| 29 | 2009 | Rebecca J. Weber Controller and Dir. of Finance | 115.6K | — | — | 12.4K | 19.5K | — | 147.5K | 8.41% | ↗ |
| 30 | 2009 | Rebecca J. Weber Controller & Dir. of Finance | 115.6K | — | — | 6.6K | 19.5K | — | 141.7K | 4.62% | ↗ |
| 31 | 2008 | Fred B. Parks Chief Executive Officer | 287.4K | — | — | 4.5K | 38.4K | 82.5K | 412.8K | 1.09% | ↗ |
| 32 | 2008 | Elissa J. Lindsoe Chief Financial Officer | 121.2K | — | — | 22.8K | 20.8K | 39.3K | 204.1K | 11.19% | ↗ |
| 33 | 2008 | Kirsten Doerfert | 154.4K | 7.6K | — | 6.9K | 19.8K | — | 188.7K | 3.65% | ↗ |
| 34 | 2008 | Rebecca J. Weber Controller & Dir. of Finance | 94.0K | — | — | 3.8K | 14.3K | — | 112.1K | 3.41% | ↗ |
| 35 | 2008 | Rebecca J. Weber Controller and Dir. of Finance | 94.0K | — | — | 3.8K | 14.3K | — | 112.1K | 3.41% | ↗ |
| 36 | 2008 | Mitchell Dann Interim Chief Executive Officer | 13.8K | 30.0K | — | 12.0K | — | — | 55.8K | 21.49% | ↗ |
| 37 | 2008 | Stryker Warren Chief Executive Officer | 5.8K | — | 286.00 | 882.00 | — | 893.00 | 7.8K | 14.92% | ↗ |
| 38 | 2007 | Fred B. Parks Chief Executive Officer | 318.0K | — | — | 269.3K | — | 12.0K | 599.3K | 44.94% | ↗ |
| 39 | 2007 | Claude Tihon Chief Technology Officer | 188.3K | — | — | 11.7K | 30.0K | 683.00 | 230.7K | 5.08% | ↗ |
| 40 | 2007 | Elissa J. Lindsoe Chief Financial Officer | 132.2K | 10.0K | — | 9.6K | — | — | 151.8K | 6.29% | ↗ |
| 41 | 2006 | Fred B. Parks Chief Executive Officer and Chairman | 318.0K | — | — | — | — | 12.0K | 330.0K | 0.00% | ↗ |
| 42 | 2006 | David A. Montecalvo Vice President, Product Development and Operations | 170.0K | — | — | 25.0K | — | — | 195.0K | 12.82% | ↗ |
| 43 | 2006 | Todd E. Paulson Vice President, Finance Chief Financial Officer | 150.0K | — | — | 25.0K | — | — | 175.0K | 14.29% | ↗ |
| 44 | 2005 | Fred B. Parks Chief Executive Officer and Chairman | 318.0K | 79.5K | — | — | — | 12.0K | 409.5K | 0.00% | ↗ |
| 45 | 2005 | David A. Montecalvo Vice President, Product Development and Operations | 170.0K | 25.5K | — | 25.0K | — | — | 220.5K | 11.34% | ↗ |
| 46 | 2005 | Todd E. Paulson Vice President, Finance Chief Financial Officer | 150.0K | 22.5K | — | 20.0K | — | — | 192.5K | 10.39% | ↗ |
| 47 | 2005 | Todd E. Paulson Vice President, Finance and Chief Financial Officer | 149.8K | 22.5K | — | 20.0K | — | — | 192.3K | 10.40% | ↗ |
| 48 | 2005 | Paul R. Johnson Vice President, Sales and Marketing | 133.8K | — | — | 30.0K | — | 4.5K | 168.3K | 17.83% | ↗ |
| 49 | 2004 | Fred B. Parks Chief Executive Officer and Chairman | 325.0K | 262.5K | — | 300.0K | — | 30.0K | 917.5K | 32.70% | ↗ |
| 50 | 2004 | Paul R. Johnson Vice President, Sales | 124.3K | 107.0K | — | 50.0K | — | 4.5K | 285.8K | 17.50% | ↗ |
| 51 | 2004 | Paul R. Johnson Vice President, Sales and Marketing | 124.3K | 107.0K | — | 50.0K | — | 4.5K | 285.8K | 17.50% | ↗ |
| 52 | 2004 | Lance H. Wallin Vice President, Global Marketing | 165.0K | 74.3K | — | 22.5K | — | — | 261.8K | 8.60% | ↗ |
| 53 | 2004 | David A. Montecalvo Vice President, Product Development and Operations | 150.1K | 76.5K | — | 22.5K | — | — | 249.1K | 9.03% | ↗ |
| 54 | 2004 | Kirsten Doerfert Vice President, Business Development and Strategic Planning | 150.4K | 67.7K | — | 15.0K | — | — | 233.0K | 6.44% | ↗ |
| 55 | 2004 | Todd E. Paulson Vice President, Finance and Chief Financial Officer | 120.2K | 67.5K | — | 35.0K | — | — | 222.7K | 15.71% | ↗ |
| 56 | 2004 | Todd E. Paulson Vice President, Finance Chief Financial Officer | 120.2K | 67.5K | — | 35.0K | — | — | 222.7K | 15.71% | ↗ |
| 57 | 2003 | Michael M. Selzer, Jr. President and Chief Executive Officer | 233.5K | — | — | — | — | 44.8K | 278.3K | 0.00% | ↗ |
| 58 | 2003 | Fred B. Parks Chief Executive Officer and Chairman | 29.0K | — | — | 225.0K | — | 2.5K | 256.5K | 87.71% | ↗ |
| 59 | 2003 | Lance H. Wallin Vice President, Global Marketing | 145.3K | — | — | 100.0K | — | — | 245.3K | 40.76% | ↗ |
| 60 | 2003 | Craig G. Palmer Vice President, U.S. Sales | 163.4K | 31.4K | — | 50.0K | — | — | 244.8K | 20.43% | ↗ |
| 61 | 2003 | Christopher R. Geyen Vice President, Chief Financial Officer, Secretary and Treasurer | 140.9K | — | — | 15.0K | — | 30.3K | 186.3K | 8.05% | ↗ |
| 62 | 2003 | David A. Montecalvo Vice President, Product Development and Operations | 148.2K | — | — | 30.0K | — | — | 178.2K | 16.84% | ↗ |
| 63 | 2003 | Kirsten Doerfert Vice President, Business Development and Strategic Planning | 149.2K | — | — | 15.0K | — | — | 164.2K | 9.13% | ↗ |
| 64 | 2003 | Todd E. Paulson Vice President, Finance and Chief Financial Officer | 98.0K | 13.4K | — | 13.0K | — | — | 124.4K | 10.45% | ↗ |
| 65 | 2002 | Michael M. Selzer, Jr. President and Chief Executive Officer | 253.0K | 50.6K | — | 70.0K | — | — | 373.6K | 18.74% | ↗ |
| 66 | 2002 | Christopher R. Geyen Vice President, Chief Financial Officer, Secretary and Treasurer | 145.2K | 17.4K | — | 30.0K | — | — | 192.6K | 15.58% | ↗ |
| 67 | 2002 | David A. Montecalvo Vice President, Product Development and Operations | 137.6K | 16.5K | — | 30.0K | — | — | 184.1K | 16.30% | ↗ |
| 68 | 2002 | Kirsten Doerfert Vice President, Business Development and Strategic Planning | 142.9K | 17.1K | — | 20.0K | — | — | 180.0K | 11.11% | ↗ |
| 69 | 2002 | Craig G. Palmer Vice President, U.S. Sales | 40.0K | 8.0K | — | 75.0K | — | — | 123.0K | 60.98% | ↗ |
| 70 | 2001 | Michael M. Selzer, Jr. President and Chief Executive Officer | 220.0K | 86.9K | — | 50.0K | — | — | 356.9K | 14.01% | ↗ |
| 71 | 2001 | Kirsten Doerfert Vice President, Business Development and Strategic Planning | 136.5K | 32.4K | — | 40.0K | — | — | 208.9K | 19.15% | ↗ |
| 72 | 2001 | Christopher R. Geyen Vice President, Chief Financial Officer, Secretary and Treasurer | 130.0K | 30.8K | — | 40.0K | — | — | 200.8K | 19.92% | ↗ |
| 73 | 2001 | David A. Montecalvo Vice President, Product Development and Operations | 130.0K | 30.8K | — | 10.0K | — | — | 170.8K | 5.85% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bryon Merade | Chairman & Chief Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ULGX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
